Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan

Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan

BACKGROUND: Cerebral vasospasm (CVS) is one of the most critical factors associated with clinical outcomes of patients with subarachnoid hemorrhage (SAH). Clazosentan has been investigated worldwide as a prophylactic agent to prevent CVS. We evaluated a new CVS management protocol which included cla...

Full description

Bibliographic Details
Main Authors: Takuma Maeda, Mai Okawara, Manabu Osakabe, Hiroyuki Yamaguchi, Takahiro Maeda, Hiroki Kurita
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:World Neurosurgery: X
Subjects:
Cerebral vasospasm (CVS)
Clazosentan
Elderly patients
PIVLAZ
Subarachnoid hemorrhage (SAH)
Online Access:http://www.sciencedirect.com/science/article/pii/S2590139723001023

Internet

http://www.sciencedirect.com/science/article/pii/S2590139723001023

Similar Items